Cellectis said it has enough cash to fund operations through 2024. The company presented positive research data this past week. Cellectis has several therapies in trials, but no marketed product yet.
--Off 18.33% from its 52-week high of $82.03 hit Wednesday, Jan. 15, 2025 --Up 11.22% from its 52-week low of $60.23 hit Monday, May 5, 2025 --Down 6.45% from 52 weeks ago --Off 18.33% from its 2025 ...
The maker of shower toilets and bathroom ceramics said its third-quarter sales rose 5.3% to 794.1 million Swiss francs ($875.52 million), while operating profit rose 16.4% to 227.4 million francs.
Denver, CO—June 18, 2015—Tonight, Rose Community Foundation is hosting its 20 th Anniversary celebration at 5:00 p.m. at the Denver Center for the Performing Arts in the Seawell Grand Ballroom. The ...
City Union Bank Ltd. (CUB) reported standalone net profit for the June quarter rose marginally to ₹227 crore from ₹225 crore during the year-earlier period due to a drop in other income and increase ...
Share Market: The stock market has closed on the green mark for the third consecutive day, in the fourth trading session of the week, the Sensex closed at 72,050.38 with a rise of 227 points, while ...